arrow
M

Martina Hrabinová

military faculty of medicine
H指数:29
被引数:2,464

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Carltonine B derivatives: Synthesis and structure-activity relationship insights for selective butyrylcholinesterase inhibition

卡兰亭B衍生物:选择性丁酰胆碱酯酶抑制作用的合成与构效关系研究

2026-04-200
OAAI
Next-generation broad-spectrum reactivators for effective countermeasure against organophosphorus poisoning

下一代广谱重活化剂,用于有效对抗有机磷中毒的对策

2026-03-160
OAAI
A case report of fatal chlormequat poisoning: Identification of potential additional mechanism of toxicity

一例致命矮壮素中毒的病例报告:潜在额外毒性机制的鉴定

2025-11-040
OA
Nanodiamond Mediated Delivery of Pyridinium Oxime Antidotes to Central Nervous System for Potential Treatment of Exposure to Nerve Agents

纳米金刚石介导的吡啶氧肟酸类解毒剂向中枢神经系统的递送,用于潜在治疗神经毒剂暴露。

2025-08-160
PRE
Dizocilpine derivatives as neuroprotective NMDA receptor antagonists without psychomimetic side effects
2024-12-010
OAAI
Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition

苯氧他克林衍生物: 低毒性神经保护剂,对ifenprodil结合位点和胆碱酯酶抑制具有亲和力

2024-02-018
OAAI
Highly selective butyrylcholinesterase inhibitors related to Amaryllidaceae alkaloids- Design, synthesis, and biological evaluation
2023-04-016
PRE
Design and synthesis of novel tacrine-indole hybrids as potential multitarget-directed ligands for the treatment of Alzheimer's disease

新型他克林-吲哚杂合物的设计与合成,作为治疗阿尔茨海默病的潜在多靶点定向配体

2021-04-088
OA
2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease

2-炔丙基氨基-萘醌衍生物作为治疗阿尔茨海默氏病的多能药物

2021-02-0122
PREAI